|
|
|
Home >
Health Conditions > ADHD > Atomoxetine
Strattera (atomoxetine)
Related Topics:
CME:
News & Research:
-
Atomoxetine at drugstore.com
-
Large Effect from
Methylphenidate, Medium Effect from Atomoxetine in ADHD - Medscape,
6/19/08
-
Atomoxetine Improves Both Symptoms and Neuropsychological Functioning in
Attention Deficit/Hyperactivity Disorder - Doctor's Guide, 11/21/07
-
Low-Dose Atomoxetine May Be Effective as ADHD Maintenance in Children -
Medscape, 12/19/06
-
Atomoxetine Improves Multiple Symptoms in ADHD With Comorbid Anxiety -
Doctor's Guide, 11/2/06
-
Study Suggests Atomoxetine Effective in Treating ADHD in Children and
Adolescents With ADHD and Reading Disorders - Doctor's Guide, 10/27/06
-
Study Suggests Atomoxetine Significantly Improved Functioning in Children
With Both ADHD and Anxiety Disorders - Doctor's Guide, 5/31/06
-
British Report Finds New Risks of ADHD Drug - Intelihealth, 2/21/06
-
ADHD: Switching to Atomoxetine Can Help - Clinical Psychiatry News, 2/06
-
Some Patients Respond Well to Reduced Doses of Atomoxetine - Clinical
Psychiatry News, 2/06
-
Acute Treatment with Atomoxetine Equally Effective in Children and
Adolescents - Doctor's Guide, 11/14/05
-
Atomoxetine (Strattera) Improves Executive Function in ADHD Patients -
Doctor's Guide, 11/10/05
-
Atomoxetine Gets Black Box Despite Dearth of Data: FDA cites increased risk
of suicidality - Clinical Psychiatry News, 11/05
-
Atomoxetine and Methylphenidate Appear Equal in Clinical Efficacy for
Children with ADHD - Doctor's Guide, 10/27/05
-
FDA Issues Advisory on ADHD Drug Strattera - WebMD, 9/29/05
- Strattera to carry suicide
warning for children - MSNBC, 9/29/05
-
ADHD Drug Eases Anxiety, Not Depression - Clinical Psychiatry News, 8/05
-
Warning Issued On ADHD Drug - Clinical Psychiatry News, 1/05
- Atomoxetine: The
First Nonstimulant for the Management of ADHD - Medscape, 12/20/04
- Warning Added to
ADHD Drug Strattera - WebMD, 12/17/04 - "If blood tests show evidence of
liver damage, the drug should also be stopped"
-
Lilly Announces Important Liver Safety Update to Strattera (Atomoxetine HCl)
Label - Doctor's Guide, 12/17/04
-
ADHD Comparison Favors Methylphenidate - Clinical Psychiatry News, 11/04
-
Atomoxetine Appears to Improve Quality of Life for Patients with
Attention-Deficit/Hyperactivity Disorder - Doctor's Guide, 10/25/04
-
Atomoxetine Unlikely to Have Long-Term Impact on Growth in Attention Deficit
Hyperactivity Disorder - Doctor's Guide, 10/25/04
-
Long-Term Atomoxetine (Strattera) Appears Safe and Well-Tolerated in
Children and Adolescents With Attention Deficit/Hyperactivity Disorder -
Doctor's Guide, 10/25/04
- Atomoxetine, a Novel
Treatment for ADHD - Medscape, 9/29/04
-
Atomoxetine Provides Pronounced Benefits in Patients with Oppositional
Defiant Disorder - Doctor's Guide, 6/22/04
-
Stimulant Beats Nonstimulant in Interim Study of ADHD Children -
Clinical Psychiatry News, 6/04
- ADHD Drugs
Square Off in the Classroom - WebMD, 5/6/04 -
"children treated with the stimulant drug Adderall
XR showed greater improvements in their behavior and attention than those
getting Strattera"
- Comparative Trial
Shows Advantages to Once-Daily Methylphenidate Over Once-Daily Atomoxetine
- Medscape, 5/5/04 -
"The first head-to-head comparative study of
once-daily atomoxetine (Strattera) with sustained-release methylphenidate
(Concerta, OROS methylphenidate) shows that children with attention deficit
hyperactivity disorder (ADHD) get more symptom relief from the
methylphenidate formulation"
-
Strattera (Atomoxetine) First-Line Therapy Option for
Attention-Deficit/Hyperactivity Disorder - Doctor's Guide, 4/27/04
-
Atomoxetine May Be Discontinued Without Risk Of Symptom Rebound Or Adverse
Effects - Doctor's Guide, 1/15/04
- ADHD Drug May
Help Curb Bed-Wetting - WebMD, 11/3/03
-
Nonstimulant Does Not Affect Sleep Onset in ADHD - Clinical Psychiatry
News Online, 11/03
-
Atomoxetine Helps Comorbid ADHD Patients - Clinical Psychiatry News
Online, 11/03
-
Atomoxetine Has Neutral Effect on Co-morbid Tics in Children With Attention
Deficit/Hyperactivity Disorder - Doctor's Guide, 10/30/03
-
Once-daily Atomoxetine Associated With Continuous Relief of Attention
Deficit/Hyperactivity Disorder Symptoms - Doctor's Guide, 10/28/03
- New ADHD
Medication Affects Sleep Less - WebMD, 10/23/03
-
Atomoxetine Appears Beneficial for Patients with Mixed ADHD and
Depressive/Anxiety Disorders - Doctor's Guide, 10/21/03
-
Stimulants More Effective than Atomoxetine for Once-Daily Treatment of
Attention Deficit/Hyperactivity Disorder - Doctor's Guide, 10/20/03
-
Atomoxetine Appears Safe and Effective for Treating Young Children with
Attention Deficit Hyperactivity Disorder - Doctor's Guide, 10/19/03
-
Atomoxetine Well Tolerated But Associated With Mild, Persistent Increase In
Heart Rate, Blood Pressure - Doctor's Guide, 7/30/03
-
Atomoxetine Effective for Adolescents With ADHD, Particularly for
Oppositionality - Doctor's Guide, 5/27/03
-
Emotional Dysregulation in Adult Attention Deficit Hyperactivity Disorder
Aided by Atomoxetine - Doctor's Guide, 5/26/03
-
Atomoxetine Helps Treat Paediatric Nocturnal Enuresis - Doctor's Guide,
5/26/03
-
Once-Daily Atomoxetine Achieves Continuous Symptom Relief in Attention
Deficit Hyperactivity Disorder - Doctor's Guide, 5/25/03
-
Long-Term Atomoxetine Keeps Attention Deficit Hyperactivity Symptoms at Bay
- Doctor's Guide, 5/23/03
-
Atomoxetine Safe and Effective in Long-Term, Open-Label Treatment of Adults
With ADHD - Doctor's Guide, 5/23/03
- New Drugs Help
Child ADHD, Adult ADHD - WebMD, 5/22/03
-
Atomoxetine Effective in Treating Attention Deficit/Hyperactivity in Girls
- Doctor's Guide, 12/12/02
-
FDA Approves Non-Stimulant ADHD Drug-- Strattera (Atomoxetine) -
Doctor's Guide, 12/2/02
-
New Studies Confirm Efficacy of Atomoxetine for ADHD Children - Clinical
Psychiatry News, 12/02
-
FDA OKs Drug On Attention Deficit Disorder - Intelihealth, 11/27/02
- Once-Daily
Atomoxetine Effective in ADHD - Medscape, 11/27/02
- Non-Stimulant
Approved for ADHD - WebMD, 11/26/02 -
"The FDA today approved Strattera, the first
non-stimulant drug for treating kids, teens, and adults with attention
deficit hyperactivity disorder (ADHD) ...
This is the first nonstimulant medicine approved for use in ADHD ... it
affects only one major brain chemical,
norepinephrine -- thought to be
important in regulating attention, impulsivity, and activity levels"
-
Once Daily Atomoxetine Effective In Attention Deficit Hyperactivity Disorder
- Doctor's Guide, 11/18/02
- Nonstimulant ADHD
Drug Studied - WebMD, 10/28/02
-
Once-Daily Strattera (Atomoxetine) Effective in Children with Attention
Deficit Hyperactivity Disorder - Doctor's Guide, 10/25/02
-
Long-Term Safety Of Atomoxetine In The Treatment Of Attention Deficit
Hyperactivity Disorder - Doctor's Guide, 8/29/02
-
FDA Issues Approvable Letter for Strattera for ADHD - Doctor's Guide,
8/14/02
- New ADHD Drug May
Be as Good as Ritalin - WebMD, 6/26/02
-
Long-Term Atomoxetine Safe in Children and Adolescents with Attention
Deficit Hyperactivity Disorder - Doctor's Guide, 5/23/02
- New Drug Promises
to Help Kids with ADHD - WebMD, 11/9/01
- New ADHD Drug Reduces
Symptoms, Improves Social and Family Functioning - Medscape, 11/7/01
- ADHD: New Info,
New Drug, Stimulants Don't Promote Substance Abuse, But If You Prefer, a New
Nonstimulant in the Works - WebMD, 5/17/01 -
"Early treatment of attention deficit hyperactivity
disorder, or ADHD, with drugs is liable to protect kids from abusing
substances later in life ... In related news at the meeting, researchers
reported what appears to be successful treatment of ADHD using a
nonstimulant drug called Atomoxetine"
Related Searches:
70518
|
|
